Organization
Department of Breast Internal Medicine, Liaoning Cancer Hospital and Institute, Shenyang, China
1 abstract
Abstract
Real-world efficacy and safety of inetetamab-based therapy in patients with HER2-positive metastatic breast cancer with prior trastuzumab exposure: A multi-center retrospective study.Org: Department of Breast Internal Medicine, Liaoning Cancer Hospital and Institute, Shenyang, China, Breast Cancer Center, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China, Cancer Center of First Hospital of Jilin University, Changchun, China, Anshan Cancer Hospital, Anshan, China, Institute of Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China,